LSTA
Lisata Therapeutics, Inc.
3.36
3 x 3.36
1 x 3.39
bid
ask
-
0.04
1.18%
2 @ 04:00 PM
3.36 +0.00 (0.00%)
| Ytd | 80.65% | |
| 1y | 17.48% |
3.36
day range
3.40
1.81
52 week range
5.07
| Open | 3.37 | Prev Close | 3.40 | Low | 3.36 | High | 3.40 | Mkt Cap | 30.60M |
| Vol | 74.41K | Avg Vol | 115.76K | EPS | -1.86 | P/E | N/A | Forward P/E | -1.20 |
| Beta | 1.22 | Short Ratio | 1.79 | Inst. Own | 9.07% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 3.32 | 200-d Avg | 3.23 | 1yr Est | 14.00 |
| Income Statement | |||
| Operating Expenses | 4.94M | ||
| Research and Development Expense | 1.20M | ||
| Selling, General and Administrative Expense | 3.74M | ||
| Operating Income | -4.94M | ||
| Income Tax Expense | -387.00K | ||
| Net Income | -4.49M | ||
| Net Income Common Stock | -4.49M | ||
| Net Income Common Stock (USD) | -4.49M | ||
| Consolidated Income | -4.49M | ||
| Earnings per Basic Share | -0.50 | ||
| Earnings per Basic Share (USD) | -0.50 | ||
| Earnings per Diluted Share | -0.50 | ||
| Earning Before Interest & Taxes (EBIT) | -4.88M | ||
| Earning Before Interest & Taxes (USD) | -4.88M | ||
| Weighted Average Shares | 9.01M | ||
| Weighted Average Shares Diluted | 9.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 13.06M | ||
| Cash and Equivalents (USD) | 13.06M | ||
| Current Assets | 14.02M | ||
| Property, Plant & Equipment Net | 16.00K | ||
| Total Assets | 14.06M | ||
| Current Liabilities | 3.32M | ||
| Total Liabilities | 3.39M | ||
| Accumulated Retained Earnings (Deficit) | -569.14M | ||
| Accumulated Other Comprehensive Income | -21.00K | ||
| Shareholders Equity | 10.93M | ||
| Shareholders Equity (USD) | 10.93M | ||
| Assets Non-Current | 39.00K | ||
| Liabilities Non-Current | 72.00K | ||
| Trade and Non-Trade Payables | 510.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.00K | ||
| Net Cash Flow from Financing | 181.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.90M | ||
| Issuance (Purchase) of Equity Shares | 340.00K | ||
| Net Cash Flow from Operations | -3.08M | ||
| Effect of Exchange Rate Changes on Cash | 6.00K | ||
| Share Based Compensation | 364.00K | ||